FDA approval
Capricor Stock Skyrockets 500% After Landmark HOPE-3 Trial Success: What’s Next for CAPR?
Capricor Therapeutics (NASDAQ: CAPR) saw its stock surge over 500% after announcing pivotal HOPE-3 Phase 3 trial results for Deramiocel in Duchenne muscular dystrophy. The trial’s success marks a potential turning point for the company’s regulatory path, finances, and future…
FDA’s New Era: Diabetes, Blood Pressure, and Gene Therapy Approvals Redefine Medication Safety and Innovation
Recent FDA decisions signal a major shift in medication safety and innovation, with landmark approvals for diabetes, blood pressure, and gene therapies. This article explores how new oral drugs, urgent recalls, and rapid gene therapy authorizations are transforming patient care…
Eli Lilly Stock Surges Amid FDA Wins and Manufacturing Expansion
Eli Lilly stock jumps as FDA approvals, major contracts, and strategic U.S. investments reshape its financial landscape, signaling a new era for the pharma giant.
Celcuity Stock Skyrockets Following Breakthrough Breast Cancer Drug Trial Results
Celcuity Inc. (NASDAQ: CELC) shares surged over 100% after the company announced breakthrough Phase 3 trial results for its breast cancer drug, gedatolisib. The trial demonstrated unprecedented efficacy in slowing disease progression in advanced breast cancer patients.
FDA Approves At-Home HPV Test for Cervical Cancer Screening
The FDA has approved the Teal Wand, an at-home HPV test for cervical cancer screening, offering a convenient alternative to traditional pap smears.
